GBP-1 acts as a tumor suppressor in colorectal cancer cells
Authors:
- Nathalie Britzen-LaurentNBNathalie Britzen-Laurent
- Karoline LipnikKLKaroline Lipnik
- Matthias OckerMOMatthias Ocker
- Elisabeth NaschbergerENElisabeth Naschberger
- Vera S. SchellererVSVera S. Schellerer
- Roland S. CronerRCRoland S. Croner
- Michael ViethMVMichael Vieth
- Maximilian WaldnerMWMaximilian Waldner
- Pablo SteinbergPSPablo Steinberg
- Christine HohenadlCHChristine Hohenadl
- Michael StürzlMichael Stürzl
- 5 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 34 (1) , 153-162
Abstract
The human guanylate-binding protein 1 (GBP-1) is among the proteins the most highly induced by interferon-γ (IFN-γ) in every cell type investigated as yet. In vivo, GBP-1 expression is associated with the presence of inflammation and has been observed in autoimmune diseases, inflammatory bowel diseases (IBD) and cancer. In colorectal carcinoma (CRC), the expression of GBP-1 in the desmoplastic stroma has been previously reported to correlate with the presence of an IFN-γ-dominated T helper type 1 (Th1) micromilieu and with an increased cancer-related 5-year survival. In the present study, the analysis of GBP-1 expression in a series of 185 CRCs by immunohistochemistry confirmed that GBP-1 is expressed in stroma cells of CRCs and revealed a significantly less frequent expression in tumor cells, which was contradictory with the broad inducibility of GBP-1. Furthermore, three of six CRC cell lines treated with IFN-γ were unable to express GBP-1 indicating that colorectal tumor cells tend to downregulate GBP-1. On the contrary, non-transformed colon epithelial cells strongly expressed GBP-1 in vitro in presence of IFN-γ and in vivo in inflammatory bowel diseases. Reconstitution of GBP-1 expression in a negative CRC cell line inhibited cell proliferation, migration and invasion. Using RNA interference, we showed that GBP-1 mediates the antitumorigenic effects of IFN-γ in CRC cells. In addition, GBP-1 was able to inhibit tumor growth in vivo. Altogether, these results suggested that GBP-1 acts directly as a tumor suppressor in CRC and the loss of GBP-1 expression might indicate tumor evasion from the IFN-γ-dominated Th1 immune response.Keywords
This publication has 57 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genesInternational Journal of Cancer, 2011
- A signature of immune function genes associated with recurrence-free survival in breast cancer patientsBreast Cancer Research and Treatment, 2011
- Tumor immunosurveillance in human cancersCancer and Metastasis Reviews, 2011
- Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewThe Journal of Pathology, 2010
- The Tumor Microenvironment in Colorectal CarcinogenesisCancer Microenvironment, 2010
- Heterogeneity and plasticity of T helper cellsCell Research, 2009
- Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-γ and regulates barrier function through effects on apoptosisMucosal Immunology, 2008
- Tumor immunoediting and immunosculpting pathways to cancer progressionSeminars in Cancer Biology, 2007
- Interferon-α prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulationLaboratory Investigation, 2006